New approval provides hospitals and clinics in the Czech Republic with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, May 5, 2025 /PRNewswire/ -- Telix Pharmaceuticals ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

Officials said the 128 Slice Digital PET-CT-Omni Legend machine is north India’s first and is powered by Artificial ...

Union Minister Jitendra Singh inaugurated north India's first technology-driven cancer diagnostics laboratory, promising ...

Southern Pines is known for its equestrian heritage, and now it’s striding into the future. Last fall, Meghann Lustgarten ...

In an article published in Genomic Psychiatry, researchers from Fudan University and Shanghai University of Traditional ...

HealthCare Global and Cancer Care Kenya have brought game-changing cancer imaging and treatment technology into the country ...

In a comprehensive Genomic Press perspective article published today, researchers from Fudan University and Shanghai ...

Illuccix’s broad approval is supported by robust clinical data, including the largest Ga-68-based PSMA data set from the VISION trial 6. The approval of Illuccix® in France has the potential to ...

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

New findings from the FACEHBI study show that baseline amyloid PET scans in people with subjective cognitive decline can ...